it’s time to get Globin’ discover more about what's possible with EMPAVELI
If you're like Monica, an adult with PNH taking EMPAVELI,
Where will you go next?
explore the EMPAVELI Injector get details and resources on using the EMPAVELI Injector
you don’t have to go it alone your ApellisAssist team, including your ACE, is always at your side
learn more
see how
ACE=Apellis Care Educator; PNH=paroxysmal nocturnal hemoglobinuria.
Please see full Important Safety Information, including Boxed WARNING regarding risk of serious infections, on pages 38-39, and the full Prescribing Information and Medication Guide. EMPAVELI increases your chance of getting serious infections caused by encapsulated bacteria such as Streptococcus pneumoniae , Neisseria meningitidis , and Haemophilus influenzae type B. These serious infections may quickly become life-threatening or cause death if not recognized and treated early. 1. Y ou must complete or be up to date with the vaccines against Streptococcus pneumoniae and Neisseria meningitidis at least 2 weeks before your first dose of EMPAVELI. INDICATION AND IMPORTANT SAFETY INFORMATION What is EMPAVELI ® (pegcetacoplan)? EMPAVELI is a prescription medicine used to treat adults with a disease called paroxysmal nocturnal hemoglobinuria (PNH). What is the most important information I should know about EMPAVELI? EMPAVELI is a medicine that affects your immune system and may lower the ability of your immune system to fight infections.
APELLIS, APELLISASSIST, EMPAVELI, and their respective logos are registered trademarks of Apellis Pharmaceuticals, Inc. Other trademarks referenced herein are the property of their respective owners. ©2023-2024 Apellis Pharmaceuticals, Inc. All rights reserved. 3/24 US-PEGPNH-2300265 v2.0
Made with FlippingBook - professional solution for displaying marketing and sales documents online